Filament Health Company Top Insiders
| FLHLF Stock | USD 0.0001 0.00 0.00% |
Filament Health employs about 11 people. The company is managed by 8 executives with a total tenure of roughly 26 years, averaging almost 3.0 years of service per executive, having 1.38 employees per reported executive. Examination of Filament Health's management performance can provide insight into the company performance.
| Jon Conlin Insider Corp Director |
| Jeff Fellows Insider Head Regulatory |
Filament |
Filament Health Management Team Effectiveness
The company has return on total asset (ROA) of (0.2133) % which means that it has lost $0.2133 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4004) %, meaning that it generated substantial loss on money invested by shareholders. Filament Health's management efficiency ratios could be used to measure how well Filament Health manages its routine affairs as well as how well it operates its assets and liabilities.Filament Health holds a total of 174.95 Million outstanding shares. Filament Health Corp shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 66.23 percent of Filament Health Corp outstanding shares that are owned by insiders denotes they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Filament Health in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Filament Health, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Filament Health Workforce Comparison
Filament Health Corp is rated below average in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is currently estimated at about 327. Filament Health holds roughly 11.0 in number of employees claiming about 3% of equities under Drug Manufacturers—Specialty & Generic industry.
Filament Health Corp Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Filament Health Corp Price Series Summation is a cross summation of Filament Health price series and its benchmark/peer.
Filament Health Notable Stakeholders
A Filament Health stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Filament Health often face trade-offs trying to please all of them. Filament Health's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Filament Health's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Jon Conlin | Corp Director | Profile | |
| Jeff Fellows | Head Regulatory | Profile | |
| Benjamin Lightburn | CEO CoFounder | Profile | |
| Tom Kineshanko | CoFounder | Profile | |
| Warren Duncan | Chief Officer | Profile | |
| Lisa Ranken | Chief Officer | Profile | |
| Anna Cordon | Director Communications | Profile | |
| Ryan Moss | Chief Officer | Profile |
About Filament Health Management Performance
The success or failure of an entity such as Filament Health Corp often depends on how effective the management is. Filament Health management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Filament management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Filament management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Filament Health Corp. operates as a natural psychedelic drug discovery and extraction technology company. It propagates psychedelic plants conducts genetic research performs extraction procedures runs in-house trials and distributes IP and drug candidates to drug developers, researchers, and other licensed parties. Filament Health is traded on OTC Exchange in the United States.
Filament Health Workforce Analysis
Traditionally, organizations such as Filament Health use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Filament Health within its industry.Filament Health Manpower Efficiency
Return on Filament Health Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 841.2K | |
| Net Loss Per Executive | 1.2M |
Complementary Tools for Filament Pink Sheet analysis
When running Filament Health's price analysis, check to measure Filament Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Filament Health is operating at the current time. Most of Filament Health's value examination focuses on studying past and present price action to predict the probability of Filament Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Filament Health's price. Additionally, you may evaluate how the addition of Filament Health to your portfolios can decrease your overall portfolio volatility.
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |